
Aging Pathobiology and Therapeutics
Aging Pathobiology and Therapeutics (APT, Online ISSN 2690-1803) is open access, peer-reviewed, interdisciplinary journal available online. The journal quarterly publishes research articles, reviews, editorials, case reports, opinions, letters, abstracts, and therapeutic drug briefs relating to research on the pathobiology of aging and age-related diseases. The journal aims to provide a platform for scientists and academicians worldwide to promote, share, and discuss various new issues and developments in different areas of the pathobiology of aging and age-related diseases. Scholars from the disciplines of geriatrics, gerontology, physiology, pathology, pharmacology, toxicology, biology, neuropsychology, psychology, nursing, epidemiology, and genetics are encouraged to contribute articles to the journal.
Scientists in the field of aging research are cordially invited to participate in this "Interview" column.
Vol 4, No 2 (2022): Aging Pathobiology and Therapeutics has been published, welcome to read!
The National Institute on Aging (NIA), one of the institutes of the National Institutes of Health USA, has long provided biological resources to the biogerontology community to foster research on aging.
To provide young scholars with an active academic exchange platform for exchanging ideas with each other and with influential experts in aging and age-related diseases, and cultivate candidates for Aging Pathobiology and Therapeutics (APT), the Editorial Office plans to recruit junior Editorial Board members worldwide from now on.